Dr. Wei Wei is an Assistant Professor at the Institute for Systems Biology. He also has the positions of Affiliated Assistant Professor at the UCLA Department of Molecular and Medical Pharmacology and member of the Jonsson Comprehensive Cancer Center. He received his B.S. in Fundamental Sciences (Mathematics and Physics) at Tsinghua University (Beijing) and M.S. in Materials Sciences and Engineering at UC San Diego. He obtained his Ph.D. at California Institute of Technology in 2014 with cross-disciplinary training that included both physical and biological sciences. Before joining ISB, Wei was an Assistant Professor at UCLA until mid-2018.
Wei received the Chinese Government Award for Outstanding Student Abroad in 2013. In 2014, he was the sole recipient of the Milton and Francis Clauser Doctoral Prize – the highest honor for a Caltech Ph.D. He received the Andy Hill Cancer Research Endowment Distinguished Researchers award in 2019. Currently, he is the co-director of the NCI-funded ISB/UCLA Physical Sciences in Oncology Program (PS-OP), and a Project Lead in NCI-funded NSB Cancer Center.
Wei’s research interests reside in a highly cross-disciplinary field of BioMEMS, molecular and cellular analysis, and systems biomedicine. Wei’s group is developing and deploying a unique suite of single-cell tools and computational approaches to cultivate new understanding in cancer systems biology and address significant questions in translational cancer research.
Single-cell analysis, BioMEMS, cancer molecular diagnosis, cancer epigenetic plasticity, multivariate data analysis
2014 Ph.D. in Materials Sciences, California Institute of Technology
2008 M.S. in Materials Sciences and Engineering, UC San Diego
2005 B.S. in Fundamental Sciences (Mathematics and Physics), Tsinghua University
2323737
2RQKSFR5
Wei Wei
items
1
0
date
desc
year
1
132882
https://isbscience.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-f7efadc046d537110d267baa73929d0b%22%2C%22meta%22%3A%7B%22request_last%22%3A200%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ETPKC5T6%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Flower%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFlower%2C%20Cameron%20T.%2C%20Chunmei%20Liu%2C%20James%20R.%20Heath%2C%20Wei%20Wei%2C%20and%20Forest%20M.%20White.%202023.%20%26%23x201C%3BAbstract%204876%3A%20A%20Systems%20Pharmacology%20Approach%20to%20Discover%20Synergistic%20Targeted%20Therapy%20Combinations.%26%23x201D%3B%20%3Ci%3ECancer%20Research%3C%5C%2Fi%3E%2083%20%287_Supplement%29%3A%204876.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1538-7445.AM2023-4876%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1538-7445.AM2023-4876%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DETPKC5T6%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Abstract%204876%3A%20A%20systems%20pharmacology%20approach%20to%20discover%20synergistic%20targeted%20therapy%20combinations%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cameron%20T.%22%2C%22lastName%22%3A%22Flower%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chunmei%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Heath%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Forest%20M.%22%2C%22lastName%22%3A%22White%22%7D%5D%2C%22abstractNote%22%3A%22The%20discovery%20of%20oncogenic%20signal%20transduction%20in%20cancer%20has%20enabled%20the%20development%20and%20clinical%20use%20of%20dozens%20of%20kinase-directed%20targeted%20therapies%2C%20but%20patient%20response%20is%20often%20transient%20and%20resistance%20invariably%20develops.%20In%20the%20setting%20of%20BRAF-mutant%20melanoma%2C%20for%20instance%2C%20a%20majority%20of%20patients%20relapse%20within%20one%20year%20of%20initiating%20targeted%20therapy.%20Combination%20therapies%20blocking%20compensatory%20signaling%20pathways%20provide%20a%20strategy%20for%20boosting%20treatment%20efficacy%20and%20delaying%20resistance.%20To%20find%20synergistic%20kinase%20inhibitor%20combinations%2C%20we%20used%20a%20multimodal%20systems%20pharmacology%20approach%20to%20quantify%20the%20early%20adaptive%20signaling%20and%20gene%20regulatory%20dynamics%20in%20patient-derived%20BRAFV600E-mutant%20melanoma%20cells%20under%20oncogene%20inhibition.%20Cells%20were%20treated%20with%20vemurafenib%20or%20vehicle%20and%20sampled%20longitudinally%20at%20timepoints%20spanning%20minutes%20to%20days.%20To%20measure%20signaling%20dynamics%2C%20thousands%20of%20protein%20phosphorylation%20sites%20covering%20commonly%20altered%20signaling%20axes%20in%20cancer%20were%20motif-enriched%20by%20immunoprecipitation%2C%20barcoded%20with%20isobaric%20tandem%20mass%20tags%20%28TMT%29%2C%20and%20quantified%20by%20high-resolution%20mass%20spectrometry%20%28MS%29.%20The%20resulting%20time-resolved%20phosphoproteomics%20data%20showed%20rapid%20%28%26lt%3B15%20minutes%29%20and%20potent%20%28%26gt%3B8-fold%29%20downregulation%20of%20ERK1%5C%2F2%2C%20confirming%20strong%20BRAF%20inhibition.%20Statistical%20integration%20of%20signaling%20measurements%20with%20time-series%20RNA-seq%20data%20collected%20at%20the%20same%20timepoints%20enabled%20reconstruction%20of%20multi-scale%20regulatory%20networks%20governing%20the%20adaptive%20response%20to%20oncogene%20inhibition.%20In%20particular%2C%20we%20observed%20early%20induction%20of%20SRC-family%20kinase%20%28SFK%29%20signaling%20and%20a%20broad%20cytoskeletal%20signaling%20module%2C%20implicating%20a%20compensatory%20prosurvival%20signaling%20program.%20The%20induction%20intensified%20over%20the%203-day%20treatment%20window%20and%20was%20fully%20reversed%20following%20a%206-day%20drug%20holiday%2C%20suggesting%20a%20reversible%20nature%20of%20drug%20adaptation.%20Immunoblotting%20confirmed%20sustained%20loss%20of%20ERK1%5C%2F2%20activity%20and%20concomitant%20elevated%20SFK%20phosphorylation%20following%20drug%20treatment.%20Accumulation%20of%20reactive%20oxygen%20species%2C%20a%20known%20activator%20of%20SFKs%2C%20strongly%20correlated%20with%20SFK%20activity%2C%20and%20both%20were%20ablated%20following%20treatment%20with%20the%20antioxidant%20precursor%20N-acetylcysteine.%20This%20adaptive%20response%20predicted%20a%20significant%20degree%20of%20synergy%20between%20vemurafenib%20and%20the%20pan-SFK%20inhibitor%20dasatinib%2C%20which%20was%20validated%20in%20a%20panel%20of%20patient-derived%20melanoma%20cell%20lines%20and%20in%20melanoma%20xenograft%20mouse%20models.%20Targeted%20MS%20of%20phospho-ERK1%5C%2F2%20and%20canonical%20SFK%20substrates%2C%20including%20CTTN%2C%20PXN%2C%20and%20PAG1%2C%20validated%20the%20mechanism%20of%20action%20of%20this%20combination.%20Complementary%20data%20from%20patient-derived%20non%20small-cell%20lung%20cancer%20%28NSCLC%29%20cells%20under%20tyrosine%20kinase%20inhibitor%20treatment%20demonstrates%20the%20generality%20of%20our%20integrative%20approach%2C%20and%20supports%20the%20notion%20that%20SFK%20activation%20may%20be%20a%20hallmark%20response%20to%20oncogenic%20RTK-RAS-ERK%20pathway%20inhibition.Citation%20Format%3A%20Cameron%20T.%20Flower%2C%20Chunmei%20Liu%2C%20James%20R.%20Heath%2C%20Wei%20Wei%2C%20Forest%20M.%20White.%20A%20systems%20pharmacology%20approach%20to%20discover%20synergistic%20targeted%20therapy%20combinations.%20%5Babstract%5D.%20In%3A%20Proceedings%20of%20the%20American%20Association%20for%20Cancer%20Research%20Annual%20Meeting%202023%3B%20Part%201%20%28Regular%20and%20Invited%20Abstracts%29%3B%202023%20Apr%2014-19%3B%20Orlando%2C%20FL.%20Philadelphia%20%28PA%29%3A%20AACR%3B%20Cancer%20Res%202023%3B83%287_Suppl%29%3AAbstract%20nr%204876.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1158%5C%2F1538-7445.AM2023-4876%22%2C%22ISSN%22%3A%220008-5472%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1538-7445.AM2023-4876%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222023-06-30T17%3A02%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22H8HHSDL4%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ye%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EYe%2C%20Shengda%2C%20Bin%20Yang%2C%20Tingbao%20Zhang%2C%20Wei%20Wei%2C%20Zhiqiang%20Li%2C%20Jincao%20Chen%2C%20and%20Xiang%20Li.%202022.%20%26%23x201C%3BIdentification%20of%20an%20Immune-Related%20Prognostic%20Signature%20for%20Glioblastoma%20by%20Comprehensive%20Bioinformatics%20and%20Experimental%20Analyses.%26%23x201D%3B%20%3Ci%3ECells%3C%5C%2Fi%3E%2011%20%2819%29%3A%203000.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells11193000%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells11193000%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DH8HHSDL4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Identification%20of%20an%20Immune-Related%20Prognostic%20Signature%20for%20Glioblastoma%20by%20Comprehensive%20Bioinformatics%20and%20Experimental%20Analyses%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shengda%22%2C%22lastName%22%3A%22Ye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bin%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tingbao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiqiang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jincao%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Li%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Glioblastoma%20%28GBM%29%2C%20which%20has%20a%20poor%20prognosis%2C%20accounts%20for%2031%25%20of%20all%20cancers%20in%20the%20brain%20and%20central%20nervous%20system.%20There%20is%20a%20paucity%20of%20research%20on%20prognostic%20indicators%20associated%20with%20the%20tumor%20immune%20microenvironment%20in%20GBM%20patients.%20Accurate%20tools%20for%20risk%20assessment%20of%20GBM%20patients%20are%20urgently%20needed.%20Methods%3A%20In%20this%20study%2C%20we%20used%20weighted%20gene%20co-expression%20network%20analysis%20%28WGCNA%29%20and%20differentially%20expressed%20gene%20%28DEG%29%20methods%20to%20screen%20out%20GBM-related%20genes%20among%20immune-related%20genes%20%28IRGs%29.%20Then%2C%20we%20used%20survival%20analysis%20and%20Cox%20regression%20analysis%20to%20identify%20prognostic%20genes%20among%20the%20GBM-related%20genes%20to%20further%20establish%20a%20risk%20signature%2C%20which%20was%20validated%20using%20methods%20including%20ROC%20analysis%2C%20stratification%20analysis%2C%20protein%20expression%20level%20validation%20%28HPA%29%2C%20gene%20expression%20level%20validation%20based%20on%20public%20cohorts%2C%20and%20RT-qPCR.%20In%20order%20to%20provide%20clinicians%20with%20a%20useful%20tool%20to%20predict%20survival%2C%20a%20nomogram%20based%20on%20an%20assessment%20of%20IRGs%20and%20clinicopathological%20features%20was%20constructed%20and%20further%20validated%20using%20DCA%2C%20time-dependent%20ROC%20curve%2C%20etc.%20Results%3A%20Three%20immune-related%20genes%20were%20found%3A%20PPP4C%20%28p%20%3C%200.001%2C%20HR%20%3D%200.514%29%2C%20C5AR1%20%28p%20%3C%200.001%2C%20HR%20%3D%201.215%29%2C%20and%20IL-10%20%28p%20%3C%200.001%2C%20HR%20%3D%201.047%29.%20An%20immune-related%20prognostic%20signature%20%28IPS%29%20was%20built%20to%20calculate%20risk%20scores%20for%20GBM%20patients%3B%20patients%20classified%20into%20different%20risk%20groups%20had%20significant%20differences%20in%20survival%20%28p%20%3D%200.006%29.%20Then%2C%20we%20constructed%20a%20nomogram%20based%20on%20an%20assessment%20of%20the%20IRG-based%20signature%2C%20which%20was%20validated%20as%20a%20potential%20prediction%20tool%20for%20GBM%20survival%20rates%2C%20showing%20greater%20accuracy%20than%20the%20nomogram%20without%20the%20IPS%20when%20predicting%201-year%20%280.35%20%3C%20Pt%20%3C%200.50%29%2C%203-year%20%280.65%20%3C%20Pt%20%3C%200.80%29%2C%20and%205-year%20%280.65%20%3C%20Pt%20%3C%200.80%29%20survival.%20Conclusions%3A%20In%20conclusion%2C%20we%20integrated%20bioinformatics%20and%20experimental%20approaches%20to%20construct%20an%20IPS%20and%20a%20nomogram%20based%20on%20IPS%20for%20predicting%20GBM%20prognosis.%20The%20signature%20showed%20strong%20potential%20for%20prognostic%20prediction%20and%20could%20help%20in%20developing%20more%20precise%20diagnostic%20approaches%20and%20treatments%20for%20GBM.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fcells11193000%22%2C%22ISSN%22%3A%222073-4409%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2073-4409%5C%2F11%5C%2F19%5C%2F3000%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222023-01-18T23%3A58%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22UG8FMPN4%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Su%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESu%2C%20Yapeng%2C%20Dan%20Yuan%2C%20Daniel%20G.%20Chen%2C%20Rachel%20H.%20Ng%2C%20Kai%20Wang%2C%20Jongchan%20Choi%2C%20Sarah%20Li%2C%20et%20al.%202022.%20%26%23x201C%3BMultiple%20Early%20Factors%20Anticipate%20Post-Acute%20COVID-19%20Sequelae.%26%23x201D%3B%20%3Ci%3ECell%3C%5C%2Fi%3E%200%20%280%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cell.2022.01.014%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cell.2022.01.014%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DUG8FMPN4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiple%20Early%20Factors%20Anticipate%20Post-Acute%20COVID-19%20Sequelae%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yapeng%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Yuan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20G.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20H.%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jongchan%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunga%22%2C%22lastName%22%3A%22Hong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rongyu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingyi%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergey%20A.%22%2C%22lastName%22%3A%22Kornilov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelsey%22%2C%22lastName%22%3A%22Scherler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Jimena%22%2C%22lastName%22%3A%22Pavlovitch-Bedzyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shen%22%2C%22lastName%22%3A%22Dong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Lausted%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inyoul%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Fallen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chengzhen%20L.%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priyanka%22%2C%22lastName%22%3A%22Baloni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brett%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Venkata%20R.%22%2C%22lastName%22%3A%22Duvvuri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristin%20G.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fan%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20J.%22%2C%22lastName%22%3A%22Duncombe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%20J.%22%2C%22lastName%22%3A%22McCulloch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%22%2C%22lastName%22%3A%22Rostomily%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Troisch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Mackay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quinn%22%2C%22lastName%22%3A%22DeGottardi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damon%20H.%22%2C%22lastName%22%3A%22May%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%22%2C%22lastName%22%3A%22Taniguchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20M.%22%2C%22lastName%22%3A%22Gittelman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Klinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20M.%22%2C%22lastName%22%3A%22Snyder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Roper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gladys%22%2C%22lastName%22%3A%22Wojciechowska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Murray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rick%22%2C%22lastName%22%3A%22Edmark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lesley%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yong%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%22%2C%22lastName%22%3A%22Rowen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Chour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%20A.%22%2C%22lastName%22%3A%22Algren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20R.%22%2C%22lastName%22%3A%22Berrington%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20A.%22%2C%22lastName%22%3A%22Wallick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20A.%22%2C%22lastName%22%3A%22Cochran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20E.%22%2C%22lastName%22%3A%22Micikas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christos%20J.%22%2C%22lastName%22%3A%22Petropoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hunter%20R.%22%2C%22lastName%22%3A%22Cole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trevan%20D.%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dave%20S.%20B.%22%2C%22lastName%22%3A%22Hoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20D.%22%2C%22lastName%22%3A%22Price%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naeha%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20A.%22%2C%22lastName%22%3A%22Hill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Hadlock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20T.%22%2C%22lastName%22%3A%22Magis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoni%22%2C%22lastName%22%3A%22Ribas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lewis%20L.%22%2C%22lastName%22%3A%22Lanier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20D.%22%2C%22lastName%22%3A%22Boyd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Bluestone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Chu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leroy%22%2C%22lastName%22%3A%22Hood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Gottardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%20D.%22%2C%22lastName%22%3A%22Greenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20M.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20D.%22%2C%22lastName%22%3A%22Goldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Heath%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2022.01.014%22%2C%22ISSN%22%3A%220092-8674%2C%201097-4172%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cell.com%5C%2Fcell%5C%2Fabstract%5C%2FS0092-8674%2822%2900072-1%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222022-01-31T17%3A51%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22HWR58LIU%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guo%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuo%2C%20Zhili%2C%20Hanjun%20Cheng%2C%20Zhonghan%20Li%2C%20Shiqun%20Shao%2C%20Priyanka%20Sarkar%2C%20Siwen%20Wang%2C%20Rohit%20Chaudhuri%2C%20et%20al.%202021.%20%26%23x201C%3BSingle-Cell%20Profiling%20of%20Fatty%20Acid%20Uptake%20Using%20Surface-Immobilized%20Dendrimers.%26%23x201D%3B%20%3Ci%3EJournal%20of%20the%20American%20Chemical%20Society%3C%5C%2Fi%3E%20143%20%2829%29%3A%2011191%26%23x2013%3B98.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fjacs.1c05103%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fjacs.1c05103%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DHWR58LIU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-Cell%20Profiling%20of%20Fatty%20Acid%20Uptake%20Using%20Surface-Immobilized%20Dendrimers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhili%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanjun%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhonghan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shiqun%22%2C%22lastName%22%3A%22Shao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priyanka%22%2C%22lastName%22%3A%22Sarkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siwen%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rohit%22%2C%22lastName%22%3A%22Chaudhuri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20G.%22%2C%22lastName%22%3A%22Perkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fei%22%2C%22lastName%22%3A%22Ji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Xue%22%7D%5D%2C%22abstractNote%22%3A%22We%20present%20a%20chemical%20approach%20to%20profile%20fatty%20acid%20uptake%20in%20single%20cells.%20We%20use%20azide-modified%20analogues%20to%20probe%20the%20fatty%20acid%20influx%20and%20surface-immobilized%20dendrimers%20with%20dibenzocyclooctyne%20%28DBCO%29%20groups%20for%20detection.%20A%20competition%20between%20the%20fatty%20acid%20probes%20and%20BHQ2-azide%20quencher%20molecules%20generates%20fluorescence%20signals%20in%20a%20concentration-dependent%20manner.%20By%20integrating%20this%20method%20onto%20a%20microfluidics-based%20multiplex%20protein%20analysis%20platform%2C%20we%20resolved%20the%20relationships%20between%20fatty%20acid%20influx%2C%20oncogenic%20signaling%20activities%2C%20and%20cell%20proliferation%20in%20single%20glioblastoma%20cells.%20We%20found%20that%20p70S6K%20and%204EBP1%20differentially%20correlated%20with%20fatty%20acid%20uptake.%20We%20validated%20that%20cotargeting%20p70S6K%20and%20fatty%20acid%20metabolism%20synergistically%20inhibited%20cell%20proliferation.%20Our%20work%20provided%20the%20first%20example%20of%20studying%20fatty%20acid%20metabolism%20in%20the%20context%20of%20protein%20signaling%20at%20single-cell%20resolution%20and%20generated%20new%20insights%20into%20cancer%20biology.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Fjacs.1c05103%22%2C%22ISSN%22%3A%221520-5126%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222021-10-14T23%3A30%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22JPXUSGH8%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cheng%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECheng%2C%20Hanjun%2C%20Zhonghan%20Li%2C%20Zhili%20Guo%2C%20Shiqun%20Shao%2C%20Li%20Mo%2C%20Wei%20Wei%2C%20and%20Min%20Xue.%202021.%20%26%23x201C%3BSingle-Cell%20Profiling%20of%20D-2-Hydroxyglutarate%20Using%20Surface-Immobilized%20Resazurin%20Analogs.%26%23x201D%3B%20%3Ci%3EBiosensors%20%26amp%3B%20Bioelectronics%3C%5C%2Fi%3E%20190%3A%20113368.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bios.2021.113368%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bios.2021.113368%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DJPXUSGH8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-cell%20profiling%20of%20D-2-hydroxyglutarate%20using%20surface-immobilized%20resazurin%20analogs%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanjun%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhonghan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhili%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shiqun%22%2C%22lastName%22%3A%22Shao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Mo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Xue%22%7D%5D%2C%22abstractNote%22%3A%22D-2-hydroxyglutarate%20%28D2HG%29%20is%20over-produced%20as%20an%20oncometabolite%20due%20to%20mutations%20in%20isocitrate%20dehydrogenases%20%28IDHs%29.%20Accumulation%20of%20D2HG%20can%20cause%20the%20dysfunction%20of%20many%20enzymes%20and%20genome-wide%20epigenetic%20alterations%2C%20which%20can%20promote%20oncogenesis.%20Quantification%20of%20D2HG%20at%20single-cell%20resolution%20can%20help%20understand%20the%20phenotypic%20signatures%20of%20IDH-mutant%20cancers%20and%20identify%20effective%20therapeutics.%20In%20this%20study%2C%20we%20developed%20an%20analytical%20method%20to%20detect%20D2HG%20levels%20in%20single%20cancer%20cells%20by%20adapting%20cascade%20enzymatic%20reactions%20on%20a%20resazurin-based%20fluorescence%20reporter.%20The%20resazurin%20probe%20was%20immobilized%20to%20the%20sensing%20surface%20via%20biotin-streptavidin%20interaction.%20This%20surface%20chemistry%20was%20rationally%20optimized%20to%20translate%20the%20D2HG%20levels%20to%20sensitive%20fluorescence%20readouts%20efficiently.%20This%20D2HG%20assay%20demonstrated%20good%20selectivity%20and%20high%20sensitivity%20toward%20D2HG%2C%20and%20it%20was%20compatible%20with%20the%20previously%20developed%20single-cell%20barcode%20chip%20%28SCBC%29%20technology.%20Using%20the%20SCBC%20platform%2C%20we%20performed%20simultaneous%20single-cell%20profiling%20of%20D2HG%2C%20glucose%20uptake%2C%20and%20critical%20oncogenic%20signaling%20proteins%20in%20single%20IDH-mutant%20glioma%20cells.%20The%20results%20unveiled%20the%20complex%20interplays%20between%20metabolic%20and%20oncogenic%20signaling%20and%20led%20to%20the%20identification%20of%20effective%20combination%20targeted%20therapy%20against%20these%20IDH-mutant%20glioma%20cells.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bios.2021.113368%22%2C%22ISSN%22%3A%221873-4235%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222021-10-14T23%3A29%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22S2J7VAPJ%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Su%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESu%2C%20Yapeng%2C%20Dan%20Yuan%2C%20Daniel%20G.%20Chen%2C%20Kai%20Wang%2C%20Jongchan%20Choi%2C%20Chengzhen%20L.%20Dai%2C%20Sunga%20Hong%2C%20et%20al.%202021.%20%26%23x201C%3BHeterogeneous%20Immunological%20Recovery%20Trajectories%20Revealed%20in%20Post-Acute%20COVID-19.%26%23x201D%3B%20%3Ci%3EMedRxiv%3C%5C%2Fi%3E%2C%202021.03.19.21254004.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2021.03.19.21254004%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1101%5C%2F2021.03.19.21254004%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DS2J7VAPJ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Heterogeneous%20immunological%20recovery%20trajectories%20revealed%20in%20post-acute%20COVID-19%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yapeng%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Yuan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20G.%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jongchan%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chengzhen%20L.%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunga%22%2C%22lastName%22%3A%22Hong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rongyu%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingyi%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelsey%22%2C%22lastName%22%3A%22Scherler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Jimena%22%2C%22lastName%22%3A%22Pavlovitch-Bedzyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shen%22%2C%22lastName%22%3A%22Dong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Lausted%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20H.%22%2C%22lastName%22%3A%22Ng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inyoul%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Fallen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergey%20A.%22%2C%22lastName%22%3A%22Kornilov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priyanka%22%2C%22lastName%22%3A%22Baloni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Venkata%20R.%22%2C%22lastName%22%3A%22Duvvuri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristin%20G.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fan%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%22%2C%22lastName%22%3A%22Rostomily%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Troisch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brett%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Mackay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Murray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rick%22%2C%22lastName%22%3A%22Edmark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lesley%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yong%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%22%2C%22lastName%22%3A%22Rowen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Chour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20R.%22%2C%22lastName%22%3A%22Berrington%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20A.%22%2C%22lastName%22%3A%22Wallick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%20A.%22%2C%22lastName%22%3A%22Algren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22the%20ISB-Swedish%20COVID19%20Biobanking%22%2C%22lastName%22%3A%22Unit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Terri%22%2C%22lastName%22%3A%22Wrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christos%20J.%22%2C%22lastName%22%3A%22Petropoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20D.%22%2C%22lastName%22%3A%22Price%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naeha%22%2C%22lastName%22%3A%22Subramanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Hadlock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20T.%22%2C%22lastName%22%3A%22Magis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoni%22%2C%22lastName%22%3A%22Ribas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lewis%20L.%22%2C%22lastName%22%3A%22Lanier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20D.%22%2C%22lastName%22%3A%22Boyd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20A.%22%2C%22lastName%22%3A%22Bluestone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leroy%22%2C%22lastName%22%3A%22Hood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Gottardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%20D.%22%2C%22lastName%22%3A%22Greenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20M.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20D.%22%2C%22lastName%22%3A%22Goldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Heath%22%7D%5D%2C%22abstractNote%22%3A%22%3Ch3%3EAbstract%3C%5C%2Fh3%3E%20%3Cp%3EThe%20immunological%20picture%20of%20how%20different%20patients%20recover%20from%20COVID-19%2C%20and%20how%20those%20recovery%20trajectories%20are%20influenced%20by%20infection%20severity%2C%20remain%20unclear.%20We%20investigated%20140%20COVID-19%20patients%20from%20diagnosis%20to%20convalescence%20using%20clinical%20data%2C%20viral%20load%20assessments%2C%20and%20multi-omic%20analyses%20of%20blood%20plasma%20and%20circulating%20immune%20cells.%20Immune-phenotype%20dynamics%20resolved%20four%20recovery%20trajectories.%20One%20trajectory%20signals%20a%20return%20to%20pre-infection%20healthy%20baseline%2C%20while%20the%20other%20three%20are%20characterized%20by%20differing%20fractions%20of%20persistent%20cytotoxic%20and%20proliferative%20T%20cells%2C%20distinct%20B%20cell%20maturation%20processes%2C%20and%20memory-like%20innate%20immunity.%20We%20resolve%20a%20small%20panel%20of%20plasma%20proteins%20that%2C%20when%20measured%20at%20diagnosis%2C%20can%20predict%20patient%20survival%20and%20recovery-trajectory%20commitment.%20Our%20study%20offers%20novel%20insights%20into%20post-acute%20immunological%20outcomes%20of%20COVID-19%20that%20likely%20influence%20long-term%20adverse%20sequelae.%3C%5C%2Fp%3E%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1101%5C%2F2021.03.19.21254004%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.medrxiv.org%5C%2Fcontent%5C%2F10.1101%5C%2F2021.03.19.21254004v1%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222021-06-04T19%3A50%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22T9K3NVGQ%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yang%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EYang%2C%20Liu%2C%20Xiaowei%20Yan%2C%20Jie%20Chen%2C%20Qiong%20Zhan%2C%20Yingqi%20Hua%2C%20Shili%20Xu%2C%20Ziming%20Li%2C%20et%20al.%202021.%20%26%23x201C%3BHexokinase%202%20Discerns%20a%20Novel%20Circulating%20Tumor%20Cell%20Population%20Associated%20with%20Poor%20Prognosis%20in%20Lung%20Cancer%20Patients.%26%23x201D%3B%20%3Ci%3EProceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America%3C%5C%2Fi%3E%20118%20%2811%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1073%5C%2Fpnas.2012228118%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1073%5C%2Fpnas.2012228118%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DT9K3NVGQ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hexokinase%202%20discerns%20a%20novel%20circulating%20tumor%20cell%20population%20associated%20with%20poor%20prognosis%20in%20lung%20cancer%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liu%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaowei%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiong%22%2C%22lastName%22%3A%22Zhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingqi%22%2C%22lastName%22%3A%22Hua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shili%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziming%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhuo%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Dong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dongqing%22%2C%22lastName%22%3A%22Zuo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Xue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yin%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harvey%20R.%22%2C%22lastName%22%3A%22Herschman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shun%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qihui%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%5D%2C%22abstractNote%22%3A%22Unlike%20other%20epithelial%20cancer%20types%2C%20circulating%20tumor%20cells%20%28CTCs%29%20are%20less%20frequently%20detected%20in%20the%20peripheral%20blood%20of%20non-small%20cell%20lung%20cancer%20%28NSCLC%29%20patients%20using%20epithelial%20marker-based%20detection%20approaches%20despite%20the%20aggressive%20nature%20of%20NSCLC.%20Here%2C%20we%20demonstrate%20hexokinase-2%20%28HK2%29%20as%20a%20metabolic%20function-associated%20marker%20for%20the%20detection%20of%20CTCs.%20In%2059%20NSCLC%20patients%20bearing%20cytokeratin-positive%20%28CKpos%29%20primary%20tumors%2C%20HK2%20enables%20resolving%20cytokeratin-negative%20%28HK2high%5C%2FCKneg%29%20CTCs%20as%20a%20prevalent%20population%20in%20about%20half%20of%20the%20peripheral%20blood%20samples%20with%20positive%20CTC%20counts.%20However%2C%20HK2high%5C%2FCKneg%20tumor%20cells%20are%20a%20minority%20population%20in%20pleural%20effusions%20and%20cerebrospinal%20fluids.%20Single-cell%20analysis%20shows%20that%20HK2high%5C%2FCKneg%20CTCs%20exhibit%20smaller%20sizes%20but%20consistent%20copy%20number%20variation%20profiles%20compared%20with%20CKpos%20counterparts.%20Single-cell%20transcriptome%20profiling%20reveals%20that%20CK%20expression%20levels%20of%20CTCs%20are%20independent%20of%20their%20epithelial-to-mesenchymal%20transition%20%28EMT%29%20status%2C%20challenging%20the%20long-standing%20association%20between%20CK%20expression%20and%20EMT.%20HK2high%5C%2FCKneg%20CTCs%20display%20metastasis%20and%20EGFR%20inhibitor%20resistance-related%20molecular%20signatures%20and%20are%20selectively%20enriched%20in%20patients%20with%20EGFR%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20L858R%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20driver%20oncogene%20mutation%20as%20opposed%20to%20EGFR%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2019Del%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20which%20is%20more%20frequently%20found%20in%20patients%20with%20prevalent%20CKpos%20CTCs%20in%20the%20blood.%20Consistently%2C%20treatment-na%5Cu00efve%20patients%20with%20a%20larger%20number%20or%20proportion%20of%20HK2high%5C%2FCKneg%20CTCs%20in%20the%20blood%20exhibit%20poor%20therapy%20response%20and%20shorter%20progression-free%20survival.%20Collectively%2C%20our%20approach%20resolves%20a%20more%20complete%20spectrum%20of%20CTCs%20in%20NSCLC%20that%20can%20potentially%20be%20exploited%20to%20identify%20patient%20prognosis%20before%20therapy.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1073%5C%2Fpnas.2012228118%22%2C%22ISSN%22%3A%221091-6490%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222021-06-04T19%3A18%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22SXATSQ53%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Su%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESu%2C%20Yapeng%2C%20Guideng%20Li%2C%20Melissa%20Ko%2C%20Hanjun%20Cheng%2C%20Ronghui%20Zhu%2C%20Min%20Xue%2C%20Lidia%20Robert%2C%20et%20al.%202020.%20%26%23x201C%3BAbstract%206585%3A%20Systems%20Biology%20for%20Investigating%20Drug%20Resistance%20Mechanism%20of%20Melanoma.%26%23x201D%3B%20%3Ci%3ECancer%20Research%3C%5C%2Fi%3E%2080%20%2816%20Supplement%29%3A%206585%26%23x2013%3B6585.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1538-7445.AM2020-6585%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1538-7445.AM2020-6585%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DSXATSQ53%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Abstract%206585%3A%20Systems%20biology%20for%20investigating%20drug%20resistance%20mechanism%20of%20melanoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yapeng%22%2C%22lastName%22%3A%22Su%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guideng%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Ko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanjun%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronghui%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Xue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lidia%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Levine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoni%22%2C%22lastName%22%3A%22Ribas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Garry%22%2C%22lastName%22%3A%22Nolan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvia%22%2C%22lastName%22%3A%22Plevritis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Baltimore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Heath%22%7D%5D%2C%22abstractNote%22%3A%22Integrated%20proteomic%20and%20metabolic%20single-cell%20assays%20reveal%20multiple%20independent%20adaptive%20responses%20to%20drug%20tolerance%20in%20a%20BRAF-mutant%20melanoma%20cell%20line%5CnCancers%20commonly%20develop%20resistance%20against%20chemotherapeutics%20or%20targeted%20therapies%20through%20various%20types%20of%20genetic%20or%20non-genetic%20mechanisms.%20Non-genetic%20mechanisms%20have%20been%20shown%20to%20occur%20early%20on%20and%20can%20provide%20a%20latent%20reservoir%20of%20cells%20for%20the%20emergence%20of%20various%20different%20type%20of%20mechanisms%2C%20yet%20very%20limited%20understanding%20of%20process%20were%20resolve%20main%20from%20bulk%20analysis.%20Considering%20the%20heterogeneous%20nature%20of%20the%20tumor%20cells%2C%20a%20single-cell%20level%20characterization%20of%20the%20process%20worth%20detailed%20further%20investigation.%20Using%20MAPK%20inhibition%20of%20BRAF-mutant%20melanomas%20as%20a%20model%20system%2C%20we%20resolved%20that%20cells%20take%20different%20paths%20to%20go%20from%20drug-sensitive%20to%20drug-resistant%20state.%20Using%20a%20microfludic-based%20single-cell%20integrated%20proteomic%20and%20metabolic%20assay%2C%20we%20assayed%20for%20a%20panel%20of%20signaling%2C%20phenotypic%2C%20and%20metabolic%20regulators%20at%20four%20time%20points%20during%20the%20first%20five%20days%20of%20drug%20treatment.%20Dimensional%20reduction%20of%20the%20resultant%20data%20set%2C%20coupled%20with%20information%20theoretic%20analysis%2C%20uncovered%20a%20complex%20cell%20state%20landscape%20and%20identified%20two%20distinct%20paths%20connecting%20drug-na%5Cu00efve%20and%20drug-tolerant%20states.%20Cells%20are%20shown%20to%20exclusively%20traverse%20one%20of%20the%20two%20pathways%20depending%20on%20the%20level%20of%20the%20lineage%20restricted%20transcription%20factor%20MITF%20in%20the%20drug-na%5Cu00efve%20cells.%20The%20two%20trajectories%20are%20associated%20with%20distinct%20signaling%20and%20metabolic%20susceptibilities%2C%20and%20are%20independently%20druggable.%20Our%20results%20update%20the%20paradigm%20of%20adaptive%20resistance%20development%20in%20an%20isogenic%20cell%20population%20and%20offer%20insight%20into%20the%20design%20of%20more%20effective%20combination%20therapies.%5CnCitation%20Format%3A%20Yapeng%20Su%2C%20Guideng%20Li%2C%20Melissa%20Ko%2C%20Hanjun%20Cheng%2C%20Ronghui%20Zhu%2C%20Min%20Xue%2C%20Lidia%20Robert%2C%20Raphael%20Levine%2C%20Antoni%20Ribas%2C%20Garry%20Nolan%2C%20Wei%20Wei%2C%20Sylvia%20Plevritis%2C%20David%20Baltimore%2C%20James%20R.%20Heath.%20Systems%20biology%20for%20investigating%20drug%20resistance%20mechanism%20of%20melanoma%20%5Babstract%5D.%20In%3A%20Proceedings%20of%20the%20Annual%20Meeting%20of%20the%20American%20Association%20for%20Cancer%20Research%202020%3B%202020%20Apr%2027-28%20and%20Jun%2022-24.%20Philadelphia%20%28PA%29%3A%20AACR%3B%20Cancer%20Res%202020%3B80%2816%20Suppl%29%3AAbstract%20nr%206585.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1158%5C%2F1538-7445.AM2020-6585%22%2C%22ISSN%22%3A%220008-5472%2C%201538-7445%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fcancerres.aacrjournals.org%5C%2Fcontent%5C%2F80%5C%2F16_Supplement%5C%2F6585%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222021-07-27T15%3A55%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22NNMSXDVC%22%2C%22library%22%3A%7B%22id%22%3A2323737%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWang%2C%20Zhuo%2C%20Jie%20Chen%2C%20Liu%20Yang%2C%20Mingzhe%20Cao%2C%20Yanlan%20Yu%2C%20Rulin%20Zhang%2C%20Heng%20Quan%2C%20et%20al.%202020.%20%26%23x201C%3BSingle-Cell%20Sequencing-Enabled%20Hexokinase%202%20Assay%20for%20Noninvasive%20Bladder%20Cancer%20Diagnosis%20and%20Screening%20by%20Detecting%20Rare%20Malignant%20Cells%20in%20Urine.%26%23x201D%3B%20%3Ci%3EAnalytical%20Chemistry%3C%5C%2Fi%3E%2092%20%2824%29%3A%2016284%26%23x2013%3B92.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facs.analchem.0c04282%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facs.analchem.0c04282%3C%5C%2Fa%3E.%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fisbscience.org%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D2323737%26amp%3Bitem_key%3DNNMSXDVC%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-Cell%20Sequencing-Enabled%20Hexokinase%202%20Assay%20for%20Noninvasive%20Bladder%20Cancer%20Diagnosis%20and%20Screening%20by%20Detecting%20Rare%20Malignant%20Cells%20in%20Urine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhuo%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liu%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mingzhe%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanlan%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rulin%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heng%22%2C%22lastName%22%3A%22Quan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingqi%22%2C%22lastName%22%3A%22Hua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peihua%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qihui%22%2C%22lastName%22%3A%22Shi%22%7D%5D%2C%22abstractNote%22%3A%22Bladder%20cancer%20%28BC%29%20is%20among%20the%20most%20common%20tumors%20with%20a%20high%20recurrence%20rate%2C%20necessitating%20noninvasive%20and%20sensitive%20diagnostic%20methods.%20Accurate%20detection%20of%20exfoliated%20tumor%20cells%20%28ETCs%29%20in%20urine%20is%20crucial%20for%20noninvasive%20BC%20diagnosis%20but%20suffers%20from%20limited%20sensitivity%20when%20ETCs%20are%20rare%20and%20confounded%20by%20reactive%2C%20regenerative%2C%20or%20reparative%20cells.%20Single-cell%20sequencing%20%28SCS%29%20enables%20accurate%20detection%20of%20ETCs%20by%20surveying%20oncogenic%20driver%20mutations%20or%20genome-wide%20copy%20number%20alternations.%20To%20overcome%20the%20low-throughput%20limitation%20of%20SCS%2C%20we%20report%20a%20SCS-validated%20cellular%20marker%2C%20hexokinase%202%20%28HK2%29%2C%20for%20high-throughput%20screening%20cells%20in%20urine%20and%20detecting%20ETCs%20engaging%20elevated%20glycolysis.%20In%20the%20SCS-based%20training%20set%2C%20a%20total%20of%20385%20cells%20from%20urine%20samples%20of%20eight%20urothelial%20carcinoma%20%28UC%29%20patients%20were%20sequenced%20to%20establish%20a%20HK2%20threshold%20that%20achieved%20%3E90%25%20specificity%20for%20ETC%20detection.%20This%20urine-based%20HK2%20assay%20was%20tested%20with%20a%20blinded%20patient%20group%20%28n%20%3D%20384%29%20including%20UC%20and%20benign%20genitourinary%20disorders%20as%20a%20validation%20cohort%20for%20prospectively%20evaluating%20diagnostic%20accuracy.%20The%20sensitivity%2C%20specificity%2C%20positive%20predictive%20value%2C%20and%20negative%20predictive%20value%20of%20the%20assay%20were%2090%2C%2088%2C%2083%2C%20and%2093%25%2C%20respectively%2C%20which%20were%20superior%20to%20urinary%20cytology.%20For%20investigating%20the%20potential%20to%20be%20a%20screening%20test%2C%20the%20HK2%20assay%20was%20tested%20with%20a%20group%20of%20healthy%20individuals%20%28n%20%3D%20846%29%20and%20a%206-month%20follow-up.%20The%20specificity%20was%2098.4%25%20in%20this%20health%20group.%20Three%20participants%20were%20found%20to%20have%20%3E5%20putative%20ETCs%20that%20were%20sequenced%20to%20exhibit%20recurrent%20copy%20number%20alternations%20characteristic%20of%20malignant%20cells%2C%20demonstrating%20early%20BC%20detection%20before%20current%20clinical%20methods.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.analchem.0c04282%22%2C%22ISSN%22%3A%221520-6882%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222RQKSFR5%22%5D%2C%22dateModified%22%3A%222021-01-04T19%3A41%3A09Z%22%7D%7D%5D%7D
Flower, Cameron T., Chunmei Liu, James R. Heath, Wei Wei, and Forest M. White. 2023. “Abstract 4876: A Systems Pharmacology Approach to Discover Synergistic Targeted Therapy Combinations.”
Cancer Research 83 (7_Supplement): 4876.
https://doi.org/10.1158/1538-7445.AM2023-4876.
Cite
Ye, Shengda, Bin Yang, Tingbao Zhang, Wei Wei, Zhiqiang Li, Jincao Chen, and Xiang Li. 2022. “Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses.”
Cells 11 (19): 3000.
https://doi.org/10.3390/cells11193000.
Cite
Su, Yapeng, Dan Yuan, Daniel G. Chen, Rachel H. Ng, Kai Wang, Jongchan Choi, Sarah Li, et al. 2022. “Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae.”
Cell 0 (0).
https://doi.org/10.1016/j.cell.2022.01.014.
Cite
Guo, Zhili, Hanjun Cheng, Zhonghan Li, Shiqun Shao, Priyanka Sarkar, Siwen Wang, Rohit Chaudhuri, et al. 2021. “Single-Cell Profiling of Fatty Acid Uptake Using Surface-Immobilized Dendrimers.”
Journal of the American Chemical Society 143 (29): 11191–98.
https://doi.org/10.1021/jacs.1c05103.
Cite
Cheng, Hanjun, Zhonghan Li, Zhili Guo, Shiqun Shao, Li Mo, Wei Wei, and Min Xue. 2021. “Single-Cell Profiling of D-2-Hydroxyglutarate Using Surface-Immobilized Resazurin Analogs.”
Biosensors & Bioelectronics 190: 113368.
https://doi.org/10.1016/j.bios.2021.113368.
Cite
Su, Yapeng, Dan Yuan, Daniel G. Chen, Kai Wang, Jongchan Choi, Chengzhen L. Dai, Sunga Hong, et al. 2021. “Heterogeneous Immunological Recovery Trajectories Revealed in Post-Acute COVID-19.”
MedRxiv, 2021.03.19.21254004.
https://doi.org/10.1101/2021.03.19.21254004.
Cite
Yang, Liu, Xiaowei Yan, Jie Chen, Qiong Zhan, Yingqi Hua, Shili Xu, Ziming Li, et al. 2021. “Hexokinase 2 Discerns a Novel Circulating Tumor Cell Population Associated with Poor Prognosis in Lung Cancer Patients.”
Proceedings of the National Academy of Sciences of the United States of America 118 (11).
https://doi.org/10.1073/pnas.2012228118.
Cite
Su, Yapeng, Guideng Li, Melissa Ko, Hanjun Cheng, Ronghui Zhu, Min Xue, Lidia Robert, et al. 2020. “Abstract 6585: Systems Biology for Investigating Drug Resistance Mechanism of Melanoma.”
Cancer Research 80 (16 Supplement): 6585–6585.
https://doi.org/10.1158/1538-7445.AM2020-6585.
Cite
Wang, Zhuo, Jie Chen, Liu Yang, Mingzhe Cao, Yanlan Yu, Rulin Zhang, Heng Quan, et al. 2020. “Single-Cell Sequencing-Enabled Hexokinase 2 Assay for Noninvasive Bladder Cancer Diagnosis and Screening by Detecting Rare Malignant Cells in Urine.”
Analytical Chemistry 92 (24): 16284–92.
https://doi.org/10.1021/acs.analchem.0c04282.
Cite
Wei Lab
Institute for Systems Biology
401 Terry Ave N
Seattle WA 98109
Email: wwei@isbscience.org
isbscience.org/bio/wei-wei/
